Reiko Sugiura

Title: Reiko Sugiura: Innovator in Antitumor Agents and Drug Delivery Solutions

Introduction

Reiko Sugiura is a notable inventor based in Higashiosaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents and innovative drug delivery systems. With a total of three patents to his name, Sugiura's work reflects a commitment to advancing medical technology.

Latest Patents

One of Sugiura's latest patents is an antitumor agent designed to provide an effective treatment option for cancer. This invention includes a glycolipid glycoside compound as an active ingredient, which is represented by a specific formula. The formula includes components that can either be an alkanoyl group or a hydrogen atom, along with a sugar alcohol or polyol residue. Another significant patent is the exposure-preventing cap, which features a novel and simple structure. This cap is designed to be mounted on a vial, effectively preventing the leakage of drug solutions when drawing them into a syringe. The cap includes a puncturing hole and a rubber membrane that forms an internal space, ensuring reliable containment of the drug solution.

Career Highlights

Throughout his career, Sugiura has worked with reputable institutions, including Kinki University and Gto LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical technology.

Collaborations

Sugiura has collaborated with several professionals in his field, including Ayako Kita and Shunji Ishiwata. These collaborations have likely enriched his research and development efforts, fostering a creative environment for innovation.

Conclusion

Reiko Sugiura's contributions to the fields of antitumor agents and drug delivery systems highlight his role as a significant inventor. His patents reflect a dedication to improving medical treatments and ensuring the safe delivery of pharmaceuticals.